Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel plus cisplatin as adjuvant chemotherapy after radical hysterectomy for stage IB–IIB cervical cancer
jRCTs051180220Recruiting
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of paclitaxel and cisplatin in Cervical Cancer (CC) (2 cohorts). Primary endpoint: Two-year disease free survival rate. Started Sep 2015; status: recruiting.
02
Drugs
paclitaxelcisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCTs051180220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180220.